News

A groundbreaking wireless implant promises real-time, personalized pain relief using AI and ultrasound power—no batteries, no ...
Treating arthritis pain and stiffness is key to living with the condition. Learn about anti-inflammatory drug treatment, side effects, and alternatives.
Zeposia has also been approved for MS and submitted for UC treatment in Europe, and BMS wants to get it to market quickly – it’s using a valuable priority review voucher to shorten the time ...
Bristol-Myers Squibb’s Zeposia (ozanimod) ... After a year’s treatment, 37% of subjects on BMS’ drug were still in remission, compared to 18.5% of those in the control arm.
Some, such as period pain, can pass with time. Others need urgent medical treatment. ... Zeposia and pregnancy, breastfeeding, and birth control.